Diffuse large B-cell lymphoma of the uterine cervix: A rare case managed novelly

被引：17

作者：

Baijal, Gunjan ^{[1
]}

Vadiraja, B. M. ^{[1
]}

Fernandes, Donald J. ^{[1
]}

Vidyasagar, M. S. ^{[1
]}

机构：

[1] Shirdi Sai Baba Canc Hosp, Kasturba Med Coll, Dept Radiotherapy & Oncol, Manipal 576104, Karnataka, India

来源：

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS | 2009年 / 5卷 / 02期

关键词：

Non-Hodgkins lymphoma; rituximab; uterine cervix; NON-HODGKINS-LYMPHOMA; CHEMOTHERAPY; UTERUS; VAGINA;

D O I：

10.4103/0973-1482.52784

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Non-Hodgkins lymphoma (NHL) of the uterine cervix is exceedingly rare. The management of the disease is not standardized. A 44-year-old lady presented with a history of bleeding pervaginum and a foul-smelling discharge of 2 months duration. A 7 x 7 growth was seen in the cervix. A biopsy revealed it to be a CD20-positive diffuse large B-cell (DLBCL)-type NHL. She was diagnosed as stage IE after staging work-up, and managed with three courses of rituximab, cyclophosphamide, vincristine, adriamycin, and prednisolone followed by external beam radiotherapy (46 Gy in 23 fractions) by 3D conformal technique. She attained a complete response, and has been in remission for 1 year 3 months.

引用

页码：140 / 142

页数：3

共 13 条

[1]

[Anonymous], 2006, SEER cancer statistics review, 1975-2003

[2]

CHORLTON I, 1974, OBSTET GYNECOL, V44, P735

[3] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].